COVID symptoms, testing, shielding impact on patient reported outcomes and early vaccine responses in individuals with multiple myeloma

Karthik Ramasamy, Ross Sadler, Sally Jeans, Sherin Varghese, Alison Turner, Jemma Larham, Nathanael Gray, Joe Barrett, Stella Bowcock, Gordon Cook, Chara Kyriakou, Dean Smith, Mark Drayson, Supratik Basu, Sally Moore, Sarah McDonald, Sarah Gooding, Muhammad K Javaid
doi: https://doi.org/10.1101/2021.05.20.21257379

Article Information

doi 
https://doi.org/10.1101/2021.05.20.21257379
History 
  • May 22, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Karthik Ramasamy, MBBS, FRCP, FRCPath, PhD, Associate Professor1,*,
  2. Ross Sadler, PhD,FRCPath, Consultant Clinical Scientist immunologist2,
  3. Sally Jeans3,
  4. Sherin Varghese, MSc, Clinical Trials Coordinator2,
  5. Alison Turner, RUDY Study Coordinator4,
  6. Jemma Larham, MSc, Physicians Associate2,
  7. Nathanael Gray4,
  8. Joe Barrett4,
  9. Stella Bowcock, MA, MBBS, MRCP, FRCPath, Consultant Haematologist5,
  10. Gordon Cook, MB.ChB., PhD, FRCP, FRCPath, Professor of Haematology6,
  11. Chara Kyriakou, MD, PhD, Consultant Haematologist7,
  12. Dean Smith, MA, MBBS, MRCP, FRCPath, MD(Res), Consultant Haematologist8,
  13. Mark Drayson, MBChB PhD FRCPath, Professor Clinical Immunodiagnostics, Honorary Consultant Immunologist9,
  14. Supratik Basu, MBBS, MD, MRCP, FRCP, FRCPath, Consultant Haematologist, Professor of Haematology10,
  15. Sally Moore, MD, Consultant Haematologist11,
  16. Sarah McDonald, MSc12,
  17. Sarah Gooding, Consultant Haematologist and Research Fellow13 and
  18. Muhammad K Javaid, MBBS BMedSci FRCP PhD NDORMS, Associate Professor4
  1. 1Oxford University Hospitals NHS Trust, Consultant Haematologist, Radcliffe department of Medicine, Oxford University
  2. 2Oxford University Hospitals NHS Trust
  3. 3RUDY Study Participant Forum Member
  4. 4Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
  5. 5King’s College Hospital NHS Trust, London
  6. 6Leeds Institute of Clinical Trials Research, University of Leeds
  7. 7University College London Hospitals NHS Trust
  8. 8Nottingham University Hospitals NHS Trust
  9. 9University of Birmingham
  10. 10University of Wolverhampton, Royal Wolverhampton NHS Trust
  11. 11Oxford University Hospitals NHS Trust, Bath Royal United Hospitals
  12. 12Director of Research, Myeloma UK
  13. 13WIMM, Oxford
  1. ↵*Corresponding Author
    : Karthik Ramasamy MBBS, FRCP, FRCPath, PhD, Oxford University Hospitals NHS Trust & Oxford University, Email : karthik.ramasamy{at}ndcls.ox.ac.uk
Back to top
Posted May 22, 2021.
Download PDF

Supplementary Material

Data/Code
Email
COVID symptoms, testing, shielding impact on patient reported outcomes and early vaccine responses in individuals with multiple myeloma
Karthik Ramasamy, Ross Sadler, Sally Jeans, Sherin Varghese, Alison Turner, Jemma Larham, Nathanael Gray, Joe Barrett, Stella Bowcock, Gordon Cook, Chara Kyriakou, Dean Smith, Mark Drayson, Supratik Basu, Sally Moore, Sarah McDonald, Sarah Gooding, Muhammad K Javaid
medRxiv 2021.05.20.21257379; doi: https://doi.org/10.1101/2021.05.20.21257379
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area